KSCP
APFCP
SIUCP-ETS
NSCRD
Search
- Page Path
- HOME > Search
Original Article
- Expression of Cyclooxygenase-2 in Colorectal Adenocarcinoma.
- Kim, Hyung Suk , Heo, Tae Gil , Hong, Seong Woo , Joo, Mee , Jang, Yeo Gu , Kweon, Do Sung , Paik, In Wook , Lee, Hyucksang
- J Korean Soc Coloproctol. 2001;17(5):259-266.
- 1,226 View
- 16 Download
-
Abstract
PDF - PURPOSE
Several studies indicate that nonsteroidal anti-inflammatory drugs including aspirin and sulindac reduce the risk of colon cancer. Futhermore, nonsteroidal anti-inflammatory drugs that inhibit the cyclooxygenase (COX) are shown to inhibit the development colon cancer in animal models of carcinogenesis. COX-1 is constitutively expressed to fulfill its beneficial housekeeping roles. COX-2 is not constitutively expressed by most normal tissues, but it is rapidly induced by certain inflammatory cytokines, tumor promoters, growth factors and oncogenes. The purpose of this study is to evaluate the role of COX-2 in colorectal carcinoma development and the correlation between COX-2 expression and tumor angiogenesis and p53 overexpression.
METHODS
Immunohistochemical analyses using antibodies against COX-2, factor VIII-related antigen, vascular endothelial growth factor (VEGF) and p53 were carried out on archival specimens of 15 colorectal adenoma and 41 adenocarcinoma.
RESULTS
COX-2 expression was increased in 5/15 (33.3%) adenomas and 24/41 (58.5%) adenocarcinomas. COX-2 expression in adenocarcinoma was nearly significantly higher than in adenoma (P=0.050). In adenocarcinoma, COX-2 expression was increased in early cancer (TNM stage) (P=0.028) and well differentiated tumor (P=0.029). COX- 2 expression was not correlated with VEGF expression, microvessel density and p53 overexpression.
CONCLUSIONS
These findings indicate that enhanced expression of COX-2 occurs early during colorectal cancer progression. However, further investigations are needed to evaluate the relationship of COX-2 and tumor angiogenesis using other laboratory methods.
First
Prev- Page of 1
- Next
- Last
TOP
